185 related articles for article (PubMed ID: 18274882)
1. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.
McTaggart-Cowan HM; Marra CA; Yang Y; Brazier JE; Kopec JA; FitzGerald JM; Anis AH; Lynd LD
Qual Life Res; 2008 Apr; 17(3):453-62. PubMed ID: 18274882
[TBL] [Abstract][Full Text] [Related]
2. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
[TBL] [Abstract][Full Text] [Related]
3. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
4. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.
Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
Qual Life Res; 2016 Dec; 25(12):3017-3026. PubMed ID: 27387417
[TBL] [Abstract][Full Text] [Related]
5. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
6. A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A; Mayo NE
Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
[TBL] [Abstract][Full Text] [Related]
7. The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D.
Young TA; Yang Y; Brazier JE; Tsuchiya A
Med Decis Making; 2011; 31(1):195-210. PubMed ID: 20525959
[TBL] [Abstract][Full Text] [Related]
8. Psychometric and utility-based measures of health status of asthmatic patients with different disease control level.
Szende A; Svensson K; Ståhl E; Mészáros A; Berta GY
Pharmacoeconomics; 2004; 22(8):537-47. PubMed ID: 15217309
[TBL] [Abstract][Full Text] [Related]
9. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
[TBL] [Abstract][Full Text] [Related]
11. The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities.
Teckle P; Peacock S; McTaggart-Cowan H; van der Hoek K; Chia S; Melosky B; Gelmon K
Health Qual Life Outcomes; 2011 Nov; 9():106. PubMed ID: 22123196
[TBL] [Abstract][Full Text] [Related]
12. Use of health status measures in patients with low back pain in clinical settings. Comparison of specific, generic and preference-based instruments.
Suarez-Almazor ME; Kendall C; Johnson JA; Skeith K; Vincent D
Rheumatology (Oxford); 2000 Jul; 39(7):783-90. PubMed ID: 10908699
[TBL] [Abstract][Full Text] [Related]
13. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
14. Validity of two common asthma-specific quality of life questionnaires: Juniper mini asthma quality of life questionnaire and Sydney asthma quality of life questionnaire.
Apfelbacher CJ; Jones C; Hankins M; Smith H
Health Qual Life Outcomes; 2012 Aug; 10():97. PubMed ID: 22906054
[TBL] [Abstract][Full Text] [Related]
15. Validity of utility measures for women with urge, stress, and mixed urinary incontinence.
Harvie HS; Shea JA; Andy UU; Propert K; Schwartz JS; Arya LA
Am J Obstet Gynecol; 2014 Jan; 210(1):85.e1-6. PubMed ID: 24055585
[TBL] [Abstract][Full Text] [Related]
16. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
[TBL] [Abstract][Full Text] [Related]
17. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
[TBL] [Abstract][Full Text] [Related]
18. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
19. The psychometric performance of generic preference-based measures for patients with pressure ulcers.
Palfreyman S; Mulhern B
Health Qual Life Outcomes; 2015 Aug; 13():117. PubMed ID: 26231179
[TBL] [Abstract][Full Text] [Related]
20. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
